Under the new law, the drugs mifepristone and misoprostol will be designated as Schedule IV controlled substances.

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

The new weight-loss drugs were originally developed as a treatment for type 2 diabetes. They work by mimicking a gut hormone usually released after eating, called GLP-1. This hormone makes people feel ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.